The purpose of this study is to learn if cognitive behavioral therapy for insomnia (CBT-I) will improve sleep quality, fatigue, and quality of life in individuals with multiple sclerosis (MS) with symptoms of insomnia.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
43
Involves attending 1 hour long sessions weekly for 6 weeks. Sessions will be one-on-one or in a group.
Involves attending 1 hour long sessions weekly for 6 weeks. Sessions will involve stretching and thinking games.
University of Kansas Medical Center
Kansas City, Kansas, United States
Insomnia Severity Index (ISI)
The ISI consists of 7 questions, each rated on a 0-4 scale. The range of scores on the ISI is 0-28, with a score of ≥ 10 suggesting clinical insomnia. The lower the score the less severe insomnia.
Time frame: Change from Baseline to Week 7
Pittsburgh Sleep Quality Index (PSQI)
The PSQI consists of 9 items within 7 sleep categories. The 7 sleep category scores are summed to form a single global score ranging from 0-21. A global score of \>5 reflects poor sleep quality.
Time frame: Change from Baseline to Week 7
Modified Fatigue Impact Scale (MFIS)
The MFIS assesses the impact of fatigue on daily activities for the month prior. The MFIS consists of 21 items with 3 subscales: physical, cognitive, and psychosocial. The score on the 21 items are scored with a range of 0-84 with a higher score indicating a greater impact of fatigue.
Time frame: Change from Baseline to Week 7
Fatigue Severity Scale (FSS)
The FSS assesses the impact of fatigue on activities for the week prior and consists of 9 questions. The mean of the 9 scores is calculated with a range of 0-7.
Time frame: Change from Baseline to Week 7
Multiple Sclerosis Impact Scale (MSIS)
Quality of life will be assessed using the Multiple Sclerosis Impact Scale (MSIS-29). MSIS-29 is total of 29 items scale, with subscales of physical (20 items) and psychological (9 items). Responses computed in a range from 0-100, and higher scores indicating a worse quality of life due to physical and physiological impacts of MS.
Time frame: Change from Baseline to Week 7
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.